Czech National Bank lifted its position in Colgate-Palmolive (NYSE:CL - Free Report) by 6.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 177,145 shares of the company's stock after purchasing an additional 10,696 shares during the quarter. Czech National Bank's holdings in Colgate-Palmolive were worth $16,104,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Reston Wealth Management LLC acquired a new stake in shares of Colgate-Palmolive in the third quarter worth $42,000. Capital Performance Advisors LLP acquired a new stake in Colgate-Palmolive during the 3rd quarter worth about $53,000. Prospera Private Wealth LLC purchased a new position in shares of Colgate-Palmolive during the 3rd quarter valued at about $64,000. True Wealth Design LLC boosted its stake in shares of Colgate-Palmolive by 1,460.9% in the third quarter. True Wealth Design LLC now owns 718 shares of the company's stock worth $75,000 after buying an additional 672 shares during the last quarter. Finally, Continuum Advisory LLC grew its holdings in Colgate-Palmolive by 93.4% during the third quarter. Continuum Advisory LLC now owns 762 shares of the company's stock worth $79,000 after acquiring an additional 368 shares during the period. Institutional investors and hedge funds own 80.41% of the company's stock.
Colgate-Palmolive Price Performance
NYSE CL traded up $0.63 during trading hours on Tuesday, hitting $87.73. 4,606,624 shares of the company's stock traded hands, compared to its average volume of 5,109,228. The company has a market capitalization of $71.68 billion, a PE ratio of 25.14, a PEG ratio of 3.31 and a beta of 0.44. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. Colgate-Palmolive has a 52-week low of $79.69 and a 52-week high of $109.30. The firm's 50-day moving average is $92.36 and its 200-day moving average is $97.92.
Colgate-Palmolive Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be paid a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.28%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive's dividend payout ratio (DPR) is presently 57.31%.
Analysts Set New Price Targets
A number of brokerages have issued reports on CL. Wells Fargo & Company decreased their price target on Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating for the company in a report on Tuesday, January 7th. JPMorgan Chase & Co. increased their price target on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the stock an "overweight" rating in a report on Friday, October 11th. Piper Sandler cut their price objective on shares of Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating for the company in a report on Monday, January 6th. StockNews.com cut Colgate-Palmolive from a "buy" rating to a "hold" rating in a research report on Thursday, January 9th. Finally, TD Cowen reduced their price target on Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating for the company in a report on Wednesday, January 8th. One research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have given a buy rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus price target of $103.63.
Read Our Latest Analysis on Colgate-Palmolive
Insider Transactions at Colgate-Palmolive
In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the business's stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the transaction, the chief financial officer now owns 36,726 shares in the company, valued at $3,456,283.86. The trade was a 55.29 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own 0.34% of the company's stock.
Colgate-Palmolive Profile
(
Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Recommended Stories
Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.